A Phase 1 Single Dose and Multiple Ascending Dose Study to Assess the Relative Bioavailability, Food Effect, Safety, Tolerability and Pharmacokinetics of SYT-510 in Healthy Participants

NCT06670950 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: SYT-510
DRUG: SYT-510
DRUG: SYT-510
DRUG: Placebo

Sponsor

Synendos Therapeutics AG